4//SEC Filing
GLENN JOHN 4
Accession 0001415889-25-010210
CIK 0001325618other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:45 PM ET
Size
9.1 KB
Accession
0001415889-25-010210
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-06-20+5,796→ 10,179 total - Exercise/Conversion
Restricted Stock Units
2024-06-20+5,796→ 11,592 totalFrom: 2024-06-20→ Common Stock (5,796 underlying) - Tax Payment
Common Stock
2024-06-20$42.53/sh−1,412$60,052→ 8,767 total
Footnotes (3)
- [F1]Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis.
- [F2]The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction.
- [F3]The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001253497
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:45 PM ET
- Size
- 9.1 KB